Resistance problem and defense mechanism
Conventional broad-spectrum semi-synthetic penicillins are vulnerable to bacterial defense mechanisms. Microorganisms produce special enzymes—beta-lactamases (penicillinases)—which successfully destroy the antibiotic before it can act.
To overcome this problem, combination drugs have been developed. They consist of the antibiotic itself and a beta-lactamase inhibitor. The inhibitors themselves possess only weak antibacterial properties and are structurally similar—they also contain a beta-lactam ring. Upon entering the body, they bind to bacterial enzymes and irreversibly inactivate them, protecting the main antibiotic from hydrolysis.
Broadening of the antimicrobial spectrum
Thanks to enzyme protection, such combination drugs are effective against microorganisms capable of producing beta-lactamases. Their activity spectrum covers:
- Gram-negative and Gram-positive bacteria: staphylococci, Klebsiella, Haemophilus influenzae, Moraxella, Shigella, and Salmonella.
- Anaerobic microorganisms, particularly the Bacteroides fragilis group.
Key combination drugs
In modern medical practice, several fixed combinations of an antibiotic with an inhibitor are used:
- Amoxicillin + clavulanic acid (known under the trade names Amoxiclav, Augmentin).
- Ampicillin + sulbactam (Unasyn).
- Piperacillin + tazobactam (Tazocin)—this combination features the broadest spectrum of antimicrobial action.
- Ticarcillin + clavulanic acid (Timentin).
Adverse reactions and side effects
The use of these drugs is associated with several potential complications:
- Allergic reactions: ranging from skin rash, urticaria, and bronchospasm to angioedema and anaphylactic shock. The pathogenesis is related to the formation of penicilloic acid during metabolism. It binds to body proteins, forming a "hapten-carrier" complex that acquires foreign immunogenic properties.
- Gastrointestinal tract: dyspepsia (nausea, vomiting, abdominal pain, diarrhea), as well as a severe and life-threatening complication—pseudomembranous colitis.
- Local reactions: pain and infiltrates at intramuscular injection sites, phlebitis upon intravenous administration.
- Superinfection: development of vaginal candidiasis or oral candidiasis.
Briefly: answers to topical questions
What dosages and administration regimens are used for the amoxicillin + clavulanic acid preparation?
Dosages and administration regimens for amoxicillin + clavulanic acid depend on the patient's age and clinical indications. For oral administration, the following regimens are used:
- Adults and children over 12 years of age weighing more than 40 kg—875+125 mg every 12 hours.
- Children from 3 months to 12 years—90+6.4 mg per day, divided into 2 doses every 12 hours.
- Children under 3 months—30 mg of amoxicillin per day, divided into 2 doses every 12 hours.
In tuberculosis therapy, carbapenems are used only in combination with amoxicillin + clavulanic acid. For adults, the dose is 1000+250 mg daily; dosing is calculated based on clavulanic acid—125 mg every 8–12 hours.
What are the absolute and relative contraindications to prescribing piperacillin with tazobactam?
Contraindications to prescribing the piperacillin-tazobactam combination in the provided sources are strictly limited to age restrictions. The drug is contraindicated in early childhood. Depending on specific clinical protocols for cystic fibrosis treatment, the age restriction for prescribing piperacillin with tazobactam is either under 3 months or under 2 years of age. Information regarding other absolute or relative contraindications is not provided.
Which drugs are incompatible with penicillins in the same syringe or infusion set?
Penicillins are pharmaceutically incompatible in the same syringe or infusion set with aminoglycosides and acetylcysteine.
- Aminoglycosides—have a positive charge, whereas penicillins are negatively charged. When mixed, a physicochemical interaction occurs, resulting in the formation of an inactive complex and precipitation, causing the drugs to lose their efficacy.
- Acetylcysteine—mixing with any antibiotics in the same syringe or solution leads to inactivation of the drug.
Class and exam questions
Which enzymes destroy conventional penicillins, and how are they combated?
Conventional penicillins are destroyed by bacterial enzymes—beta-lactamases. The solution to this problem was the addition of inhibitors (clavulanic acid, sulbactam, tazobactam), which irreversibly bind these enzymes and protect the antibiotic.
Why are inhibitor-protected penicillins active against anaerobes?
Their antimicrobial spectrum includes anaerobic bacteria, particularly members of the Bacteroides fragilis group, due to the synergistic action of the protected antibiotic.
Which drug in the group has the broadest spectrum of activity?
The combination of piperacillin with tazobactam (Tazocin) has the broadest spectrum of antimicrobial activity.
What else to study on this topic
- The mechanism of "hapten-carrier" complex formation in penicillin allergy
- Comparative characteristics of sulbactam, tazobactam, and clavulanic acid
- Clinical differences between Amoxiclav and Unasyn
- Diagnosis and treatment principles of pseudomembranous colitis
- Features of superinfection development during antibiotic therapy
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Inhibitor-protected penicillins" and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Antibacterial Chemotherapeutic Agents"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.